SAN MATEO, CA, Cala Health, the non-invasive bioelectronic medicine leader, announced it has completed the initial closing of an oversubscribed $50 million growth round.
Cala Health, the non-invasive bioelectronic medicine leader, announced it has completed the initial closing of an oversubscribed $50 million growth round, co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. All existing Cala investors participated in the round, including Action Potential, Johnson & Johnson (through its corporate venture capital organization, Johnson & Johnson Innovation - JJDC, Inc.), Lightstone, Lux Capital, GV (Google Ventures), OSF Ventures, Ascension Ventures, TriVentures, Reimagined Ventures, Peak6 and Fiscus.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
